These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 8829204

  • 1. Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose.
    Mamzoridi K, Kasteridou N, Peonides A, Niopas I.
    Pharmacol Toxicol; 1996 Jun; 78(6):417-20. PubMed ID: 8829204
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].
    Kees F, Naber KG.
    Infection; 1990 Jun; 18 Suppl 3():S150-4. PubMed ID: 2079377
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Pharmacokinetics and clinical effects of cefixime in pediatrics].
    Motohiro T, Tanaka K, Koga T, Shimada Y, Tomita S, Nishiyama T, Ishimoto K, Tominaga K, Yamashita F, Nagayama K.
    Jpn J Antibiot; 1986 Apr; 39(4):1177-200. PubMed ID: 3761546
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and cerebrospinal fluid concentrations of cefixime in infants and young children.
    Nahata MC, Kohlbrenner VM, Barson WJ.
    Chemotherapy; 1993 Apr; 39(1):1-5. PubMed ID: 8444056
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of cefixime in the young and elderly.
    Faulkner RD, Bohaychuk W, Lanc RA, Haynes JD, Desjardins RE, Yacobi A, Silber BM.
    J Antimicrob Chemother; 1988 Jun; 21(6):787-94. PubMed ID: 3410802
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The pharmacokinetics of cefixime in the fasted and fed state.
    Faulkner RD, Bohaychuk W, Haynes JD, Desjardins RE, Yacobi A, Silber BM.
    Eur J Clin Pharmacol; 1988 Jun; 34(5):525-8. PubMed ID: 3203716
    [Abstract] [Full Text] [Related]

  • 12. NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
    Weber W, Harnisch L, Zimmer M, Rokitta C, Mendes P.
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):560-4. PubMed ID: 8574507
    [Abstract] [Full Text] [Related]

  • 13. Bioequivalency of oral suspension formulations of cefixime.
    Faulkner RD, Sia LL, Barone JS, Forbes SJ, Silber BM.
    Biopharm Drug Dispos; 1989 Oct; 10(2):205-11. PubMed ID: 2706319
    [Abstract] [Full Text] [Related]

  • 14. Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens.
    Debbia EA, Marchese A, Pesce A, Saverino D, Schito GC.
    J Chemother; 1992 Jun; 4(3):131-44. PubMed ID: 1517806
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Absolute bioavailability of cefixime in man.
    Faulkner RD, Fernandez P, Lawrence G, Sia LL, Falkowski AJ, Weiss AI, Yacobi A, Silber BM.
    J Clin Pharmacol; 1988 Aug; 28(8):700-6. PubMed ID: 3216036
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M, Wu WH, Look ZM, Silber BM, Yacobi A.
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.